1. Home
  2. LQDA vs GEF Comparison

LQDA vs GEF Comparison

Compare LQDA & GEF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

LQDA

Liquidia Corporation

HOLD

Current Price

$91.70

Market Cap

5.5B

Sector

Health Care

ML Signal

HOLD

Logo Greif Inc.

GEF

Greif Inc.

HOLD

Current Price

$87.34

Market Cap

4.9B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
LQDA
GEF
Founded
2004
1877
Country
United States
United States
Employees
N/A
12000
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.5B
4.9B
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
LQDA
GEF
Price
$91.70
$87.34
Analyst Decision
Strong Buy
Hold
Analyst Count
11
3
Target Price
$41.00
$73.33
AVG Volume (30 Days)
1.3M
273.2K
Earning Date
05-08-2026
04-28-2026
Dividend Yield
N/A
3.42%
EPS Growth
51.81
N/A
EPS
0.52
N/A
Revenue
$158,320,000.00
N/A
Revenue This Year
$278.87
$0.94
Revenue Next Year
$57.13
$1.34
P/E Ratio
$173.50
$4.09
Revenue Growth
1031.18
N/A
52 Week Low
$21.15
$55.75
52 Week High
$91.57
$90.57

Technical Indicators

Market Signals
Indicator
LQDA
GEF
Relative Strength Index (RSI) 67.21 69.43
Support Level $31.99 $66.70
Resistance Level N/A N/A
Average True Range (ATR) 5.09 2.45
MACD 0.15 0.35
Stochastic Oscillator 99.45 78.36

Price Performance

Historical Comparison
LQDA
GEF

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also conducting studies on L606, an investigational, liposomal formulation of treprostinil.

About GEF Greif Inc.

Greif Inc is a producer of industrial packaging products and services with manufacturing facilities located in many countries. It offers a comprehensive line of rigid industrial packaging products, such as steel, fiber, and plastic drums, rigid intermediate bulk containers, closure systems for industrial packaging products, transit protection products, water bottles and remanufactured and reconditioned industrial containers, and services, such as container life cycle management, blending, filling, logistics, warehousing, and other packaging services. The company operates in three reportable business segments including Global Industrial Packaging, Paper Packaging and Services, and Land Management. It operates in USA, Europe, Middle East, Africa and Asia and Other Americas.

Share on Social Networks: